295 related articles for article (PubMed ID: 26178831)
41. Antifungal activity of gallic acid purified from Terminalia nigrovenulosa bark against Fusarium solani.
Nguyen DM; Seo DJ; Lee HB; Kim IS; Kim KY; Park RD; Jung WJ
Microb Pathog; 2013 Mar; 56():8-15. PubMed ID: 23333407
[TBL] [Abstract][Full Text] [Related]
42. Identification of Antifungal Compounds from Avocado Rhizobacteria (Bacillus spp.) against Fusarium spp., by a Bioassay-Guided Fractionation Approach.
Guevara-Avendaño E; Lizette Pérez-Molina M; Luis Monribot-Villanueva J; Marian Cortazar-Murillo E; Ramírez-Vázquez M; Reverchon F; Antonio Guerrero-Analco J
Chem Biodivers; 2022 Nov; 19(11):e202200687. PubMed ID: 36149759
[TBL] [Abstract][Full Text] [Related]
43. Biocontrol activity of surfactin A purified from Bacillus NH-100 and NH-217 against rice bakanae disease.
Sarwar A; Hassan MN; Imran M; Iqbal M; Majeed S; Brader G; Sessitsch A; Hafeez FY
Microbiol Res; 2018 Apr; 209():1-13. PubMed ID: 29580617
[TBL] [Abstract][Full Text] [Related]
44. Purification and characterization of a novel antifungal protein from Bacillus subtilis strain B29.
Li J; Yang Q; Zhao LH; Zhang SM; Wang YX; Zhao XY
J Zhejiang Univ Sci B; 2009 Apr; 10(4):264-72. PubMed ID: 19353744
[TBL] [Abstract][Full Text] [Related]
45. Inhibitory effect of a lipopeptide biosurfactant produced by Bacillus subtilis on planktonic and sessile cells of Trichosporon spp.
Cordeiro RA; Weslley Caracas Cedro E; Raquel Colares Andrade A; Serpa R; José de Jesus Evangelista A; Sales de Oliveira J; Santos Pereira V; Pereira Alencar L; Bruna Leite Mendes P; Cibelle Soares Farias B; Maria Maciel Melo V; Pires de Camargo Z; de Souza Collares Maia Castelo-Branco D; Sâmia Nogueira Brilhante R; Júlio Costa Sidrim J; Fábio Gadelha Rocha M
Biofouling; 2018 Mar; 34(3):309-319. PubMed ID: 29560729
[TBL] [Abstract][Full Text] [Related]
46. Rhamnolipid biosurfactant against Fusarium sacchari--the causal organism of pokkah boeng disease of sugarcane.
Goswami D; Handique PJ; Deka S
J Basic Microbiol; 2014 Jun; 54(6):548-57. PubMed ID: 23687052
[TBL] [Abstract][Full Text] [Related]
47. Broad-spectrum antifungal activity of lipopeptide brevilaterin B and its inhibition effects against Fusarium oxysporum and Penicillium chrysogenum.
Liu Y; Chen Z; Liu L; Han P; Wang X; Li S; Ma A; Jia Y
J Appl Microbiol; 2022 Feb; 132(2):1330-1342. PubMed ID: 34480826
[TBL] [Abstract][Full Text] [Related]
48. Lipopeptide surfactants: Production, recovery and pore forming capacity.
Inès M; Dhouha G
Peptides; 2015 Sep; 71():100-12. PubMed ID: 26189973
[TBL] [Abstract][Full Text] [Related]
49. Antagonistic Activities of Novel Peptides from Bacillus amyloliquefaciens PT14 against Fusarium solani and Fusarium oxysporum.
Kim YG; Kang HK; Kwon KD; Seo CH; Lee HB; Park Y
J Agric Food Chem; 2015 Dec; 63(48):10380-7. PubMed ID: 26496638
[TBL] [Abstract][Full Text] [Related]
50. Complete genome sequence of Bacillus subtilis SG6 antagonistic against Fusarium graminearum.
Zhao Y; Sangare L; Wang Y; Folly YM; Selvaraj JN; Xing F; Zhou L; Wang Y; Liu Y
J Biotechnol; 2015 Jan; 194():10-1. PubMed ID: 25483317
[TBL] [Abstract][Full Text] [Related]
51. Antifungal lipopeptides from Bacillus amyloliquefaciens strain BO7.
Romano A; Vitullo D; Di Pietro A; Lima G; Lanzotti V
J Nat Prod; 2011 Feb; 74(2):145-51. PubMed ID: 21235220
[TBL] [Abstract][Full Text] [Related]
52. Antifungal potential of lipopeptides produced by the
Hussain S; Tai B; Ali M; Jahan I; Sakina S; Wang G; Zhang X; Yin Y; Xing F
Microbiol Spectr; 2024 Apr; 12(4):e0400823. PubMed ID: 38451229
[TBL] [Abstract][Full Text] [Related]
53. Antagonistic effects of Bacillus subtilis subsp. subtilis and B. amyloliquefaciens against Macrophomina phaseolina: SEM study of fungal changes and UV-MALDI-TOF MS analysis of their bioactive compounds.
Torres MJ; Brandan CP; Petroselli G; Erra-Balsells R; Audisio MC
Microbiol Res; 2016 Jan; 182():31-9. PubMed ID: 26686611
[TBL] [Abstract][Full Text] [Related]
54. A Novel Variant of Narrow-Spectrum Antifungal Bacterial Lipopeptides That Strongly Inhibit Ganoderma boninense.
Pramudito TE; Agustina D; Nguyen TKN; Suwanto A
Probiotics Antimicrob Proteins; 2018 Mar; 10(1):110-117. PubMed ID: 29101528
[TBL] [Abstract][Full Text] [Related]
55. Anti-candida effect of bacillomycin D-like lipopeptides from Bacillus subtilis B38.
Tabbene O; Kalai L; Ben Slimene I; Karkouch I; Elkahoui S; Gharbi A; Cosette P; Mangoni ML; Jouenne T; Limam F
FEMS Microbiol Lett; 2011 Mar; 316(2):108-14. PubMed ID: 21204933
[TBL] [Abstract][Full Text] [Related]
56. Heterobasidion-growth inhibiting Bacillus subtilis A18 exhibits medium- and age-dependent production of lipopeptides.
Azeem M; Barba-Aliaga M; Borg-Karlson AK; Terenius O; Broberg A; Rajarao GK
Microbiol Res; 2019; 223-225():129-136. PubMed ID: 31178045
[TBL] [Abstract][Full Text] [Related]
57. Diversity and active mechanism of fengycin-type cyclopeptides from Bacillus subtilis XF-1 against Plasmodiophora brassicae.
Li XY; Mao ZC; Wang YH; Wu YX; He YQ; Long CL
J Microbiol Biotechnol; 2013 Mar; 23(3):313-21. PubMed ID: 23462003
[TBL] [Abstract][Full Text] [Related]
58. Lipopeptides from Bacillus velezensis induced apoptosis-like cell death in the pathogenic fungus Fusarium concentricum.
Chen M; Deng Y; Zheng M; Xiao R; Wang X; Liu B; He J; Wang J
J Appl Microbiol; 2024 Mar; 135(3):. PubMed ID: 38389225
[TBL] [Abstract][Full Text] [Related]
59. Gageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis.
Tareq FS; Lee MA; Lee HS; Lee JS; Lee YJ; Shin HJ
Mar Drugs; 2014 Jan; 12(2):871-85. PubMed ID: 24492520
[TBL] [Abstract][Full Text] [Related]
60. The Extracellular Lipopeptides and Volatile Organic Compounds of
Al-Mutar DMK; Noman M; Alzawar NSA; Qasim HH; Li D; Song F
J Fungi (Basel); 2023 Jul; 9(8):. PubMed ID: 37623568
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
